Literature DB >> 20160279

Distribution and hepatocellular carcinoma-related viral properties of hepatitis B virus genotypes in Mainland China: a community-based study.

Jianhua Yin1, Hongwei Zhang, Yongchao He, Jiaxin Xie, Shijian Liu, Wenjun Chang, Xiaojie Tan, Chunying Gu, Wei Lu, Hongyang Wang, Shengli Bi, Fuqiang Cui, Xiaofeng Liang, Stephan Schaefer, Guangwen Cao.   

Abstract

INTRODUCTION: Hepatitis B virus (HBV) genotypes, replication status, and mutations have been associated with the risk of hepatocellular carcinoma (HCC). Our aim was to study the distribution and HCC-related viral properties of HBV genotypes/subgenotypes in Mainland China.
METHODS: A multistage cluster probability sampling method was applied to select 81,775 participants between 1 and 59 years at 160 national disease surveillance points. We examined hepatitis B surface antigen, HBV genotypes and subgenotypes, hepatitis B e antigen, viral load, and mutations in the PreS and core promoter regions of HBV genome.
RESULTS: HBV subgenotypes B2 (27.3%), C1 (10.7%), and C2 (58.0%) were predominant. Genotype D (D1, 80.8%) was frequent in the Uygur. We identified a new subgenotype, C9, mainly in Tibetans. Compositions of subgenotypes B2 and C1 and genotype mixture increased from the North to Central South, which was consistently associated with the increasing prevalence of hepatitis B surface antigen. Hepatitis B e antigen positivity and viral loads were higher in the young with genotype B and declined more rapidly with increasing age than those with genotype C. In contrast to G1896A, PreS deletion, T31C, T1753V, and A1762T/G1764A were more frequent in subgenotype C2 than in subgenotype B2. A1762T/G1764A, T1753V, C1653T, and G1896A, except PreS deletion, consecutively increased with increasing age.
CONCLUSION: HBV subgenotypes B2, C1, and C2 are endemic in Mainland China. HBV genotype C exhibits less replication activity in the young and harbors higher frequencies of the HCC-associated mutations than genotype B. IMPACT: These basic data could help evaluate the association of HBV variations with HCC.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20160279     DOI: 10.1158/1055-9965.EPI-09-1001

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  43 in total

1.  Exploring risk factors of hepatitis B virus-associated hepatocellular carcinoma: prospective verse retrospective studies.

Authors:  Guangwen Cao
Journal:  J Gastroenterol       Date:  2010-09-07       Impact factor: 7.527

2.  HLA-DP polymorphisms affect the outcomes of chronic hepatitis B virus infections, possibly through interacting with viral mutations.

Authors:  Qi Zhang; Jianhua Yin; Yuwei Zhang; Yang Deng; Xiaowei Ji; Yan Du; Rui Pu; Yifang Han; Jun Zhao; Xue Han; Hongwei Zhang; Guangwen Cao
Journal:  J Virol       Date:  2013-09-04       Impact factor: 5.103

Review 3.  Hepatitis B virus genotypes: epidemiological and clinical relevance in Asia.

Authors:  Qiuju Tian; Jidong Jia
Journal:  Hepatol Int       Date:  2016-06-14       Impact factor: 6.047

4.  Hepatitis B virus genotypes and genome characteristics in China.

Authors:  Hong-Mei Li; Jian-Qiong Wang; Rui Wang; Qian Zhao; Li Li; Jin-Ping Zhang; Tao Shen
Journal:  World J Gastroenterol       Date:  2015-06-07       Impact factor: 5.742

5.  Association of novel mutations and haplotypes in the preS region of hepatitis B virus with hepatocellular carcinoma.

Authors:  Jia-Xin Xie; Jun Zhao; Jian-Hua Yin; Qi Zhang; Rui Pu; Wen-Ying Lu; Hong-Wei Zhang; Hong-Yang Wang; Guang-Wen Cao
Journal:  Front Med China       Date:  2010-11-19

6.  Predictive power of hepatitis B 1762T/1764A mutations in plasma for hepatocellular carcinoma risk in Qidong, China.

Authors:  Alvaro Muñoz; Jian Guo Chen; Patricia A Egner; Melinda L Marshall; Jamie L Johnson; Michael F Schneider; Jian Hua Lu; Yuan Rong Zhu; Jin-Bing Wang; Tao Yang Chen; Thomas W Kensler; John D Groopman
Journal:  Carcinogenesis       Date:  2011-04-07       Impact factor: 4.944

Review 7.  Hepatitis B virus burden in developing countries.

Authors:  Rosa Zampino; Adriana Boemio; Caterina Sagnelli; Loredana Alessio; Luigi Elio Adinolfi; Evangelista Sagnelli; Nicola Coppola
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

8.  Association of miRNA-122-binding site polymorphism at the interleukin-1 α gene and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk.

Authors:  Yan Du; Xue Han; Rui Pu; Jiaxin Xie; Yuwei Zhang; Guangwen Cao
Journal:  Front Med       Date:  2014-04-21       Impact factor: 4.592

Review 9.  Virus-related liver cirrhosis: molecular basis and therapeutic options.

Authors:  Ji Lin; Jian-Feng Wu; Qi Zhang; Hong-Wei Zhang; Guang-Wen Cao
Journal:  World J Gastroenterol       Date:  2014-06-07       Impact factor: 5.742

10.  High prevalence of the B2+C2 subgenotype mixture in patients with chronic hepatitis B in Eastern China.

Authors:  Jun Zhong; Yue-Qiu Gao; Xue-Hua Sun; Xiao-Jun Zhu; Man Li
Journal:  Acta Pharmacol Sin       Date:  2012-09-03       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.